Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele

Detalles Bibliográficos
Autores principales: Naidoo, Anushka, Naidoo, Kogieleum, Ramsuran, Veron, Reddy, Millidhashni, Padayatchi, Nesri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574687/
https://www.ncbi.nlm.nih.gov/pubmed/28883739
http://dx.doi.org/10.2147/PGPM.S146787
_version_ 1783259889427021824
author Naidoo, Anushka
Naidoo, Kogieleum
Ramsuran, Veron
Reddy, Millidhashni
Padayatchi, Nesri
author_facet Naidoo, Anushka
Naidoo, Kogieleum
Ramsuran, Veron
Reddy, Millidhashni
Padayatchi, Nesri
author_sort Naidoo, Anushka
collection PubMed
description
format Online
Article
Text
id pubmed-5574687
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-55746872017-09-07 Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele Naidoo, Anushka Naidoo, Kogieleum Ramsuran, Veron Reddy, Millidhashni Padayatchi, Nesri Pharmgenomics Pers Med Letter Dove Medical Press 2017-08-23 /pmc/articles/PMC5574687/ /pubmed/28883739 http://dx.doi.org/10.2147/PGPM.S146787 Text en © 2017 Naidoo et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Letter
Naidoo, Anushka
Naidoo, Kogieleum
Ramsuran, Veron
Reddy, Millidhashni
Padayatchi, Nesri
Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele
title Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele
title_full Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele
title_fullStr Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele
title_full_unstemmed Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele
title_short Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele
title_sort hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the ugt1a1*28 allele
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574687/
https://www.ncbi.nlm.nih.gov/pubmed/28883739
http://dx.doi.org/10.2147/PGPM.S146787
work_keys_str_mv AT naidooanushka hyperbilirubinemiainatazanavirtreatedhumanimmunodeficiencyvirusinfectedpatientstheimpactoftheugt1a128allele
AT naidookogieleum hyperbilirubinemiainatazanavirtreatedhumanimmunodeficiencyvirusinfectedpatientstheimpactoftheugt1a128allele
AT ramsuranveron hyperbilirubinemiainatazanavirtreatedhumanimmunodeficiencyvirusinfectedpatientstheimpactoftheugt1a128allele
AT reddymillidhashni hyperbilirubinemiainatazanavirtreatedhumanimmunodeficiencyvirusinfectedpatientstheimpactoftheugt1a128allele
AT padayatchinesri hyperbilirubinemiainatazanavirtreatedhumanimmunodeficiencyvirusinfectedpatientstheimpactoftheugt1a128allele

Ejemplares similares